PROMOnc Public Comment Form
PROMOnc is developing and testing patient-reported outcome-performance measures regarding health-related quality of life and pain for patients with breast, colon and non-small cell lung cancer. We are currently seeking public comment about the PROMOnc Pre-Testing Measure Information Form (MIF). Specifically, public comment regarding the overall measure concepts and measure numerator options will be most informative at this pre-testing phase, and we also welcome feedback regarding the measure denominators and denominator exclusions. There will be future opportunities to provide feedback on the final measure specifications and data dictionary.
Thank you for choosing to provide your comments using this online form. Please review each form field below and email PBGH-PROMs@pbgh.org with any concerns or questions.